- Investing Ideas
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
14
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
14 companies
CorMedix
Market Cap: US$583.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.44
7D
-1.2%
1Y
-28.0%
Incyte
Market Cap: US$24.0b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$120.56
7D
0.9%
1Y
53.8%
Protalix BioTherapeutics
Market Cap: US$198.2m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.46
7D
3.8%
1Y
59.7%
ACADIA Pharmaceuticals
Market Cap: US$5.0b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$29.21
7D
12.9%
1Y
18.7%
Exelixis
Market Cap: US$13.4b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$54.07
7D
2.0%
1Y
43.3%
CareDx
Market Cap: US$2.3b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$46.69
7D
6.8%
1Y
290.1%
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,185.71
7D
3.2%
1Y
89.5%
Earth Science Tech
Market Cap: US$28.2m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.098
7D
-10.9%
1Y
-49.8%
Aurinia Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$15.85
7D
6.5%
1Y
39.4%
Rigel Pharmaceuticals
Market Cap: US$750.4m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$40.17
7D
9.1%
1Y
26.7%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.86
7D
5.6%
1Y
35.0%
Medpace Holdings
Market Cap: US$16.5b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$590.67
7D
2.3%
1Y
36.0%
TG Therapeutics
Market Cap: US$7.1b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$49.76
7D
-4.4%
1Y
86.3%
CapForce
Market Cap: US$55.7m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$4.50
7D
-50.9%
1Y
449,999,900.0%